Anika Therapeutics (ANIK) Tops Q2 EPS by 17c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. TSLA
6. META
7. RTX
8. SMCI
9. GOOGL
10. S

Go back to Anika Therapeutics (ANIK) Tops Q2 EPS by 17c

Anika Therapeutics Delivers Solid Second Quarter 2015 Financial Results and Continued Pipeline Progress

July 29, 2015 4:05 PM EDT

Strength in Quarter Driven by Continued Adoption of Orthobiologics Products;

Combined ORTHOVISC® and MONOVISC® U.S. Market Share Surpasses 25%

BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a leader in products for tissue protection, healing, and repair based on hyaluronic acid (HA) technology, today reported financial results for the second quarter ended June 30, 2015, along with business progress in the period.

The solid results we delivered in the second quarter demonstrate accelerating demand, which combined with our tangible pipeline progress, positions Anika... More